Advisory: Alerts on Melt Pharmaceuticals wrongly tagged to Harrow Inc withdrawn
20/11/2024 12:36
Alerts on Melt Pharmaceuticals MELT.O reporting results for a
late-stage clinical trial of its sedative drug was incorrectly
tagged and sourced to Harrow Inc HROW.O , its former parent.
Melt was spun out from Harrow as a separate entity in 2019.
For the correctly tagged alerts, click urn:newsml:reuters.com:*:nFWN3MR0A0
STORY_NUMBER: nTUABCPB7Q
STORY_DATE: 20/11/2024
STORY_TIME: 12:00:16 PM GMT
((Bangalore.newsroom@thomsonreuters.com))
Recent news on Harrow
See all newsHarrow, Inc. reports results for the quarter ended June 30 - Earnings Summary
Harrow Q2 revenue slightly beats estimates
Viatris raises annual profit forecast on branded drug strength
Brief: Harrow Re-Launches Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% For Vernal Keratoconjunctivitis, Addressing Significant Unmet Need In Pediatric Eyecare
Harrow Q1 revenue misses analyst estimates